Molecular detection of APC, K-ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers

World Journal of Surgery

Volumn 28, Issue 7, 2004, Pages 721-726

  Wang, Jaw Yuan ^a   Hsieh, Jan Sing ^a   Chang, Mei Yin ^a   Huang, Tsung Jen ^a   Chen, Fang Ming ^a   Cheng, Tian Lu ^a   Alexandersen, Ketil ^a   Huang, Yu Sheng ^a   Tzou, Wen Shyong ^a   Lin, Shiu Ru ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; CARCINOEMBRYONIC ANTIGEN; DNA; K RAS PROTEIN; PROTEIN P53;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER RECURRENCE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PROTEIN DETERMINATION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 4143133293     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-004-7366-8     Document Type: Article

References (32)

1. Coleman MP, Esteve J, Damiecki P, et al. Trends in cancer incidence and mortality. L.A.R.C. Sci. Publ. 1993;121:225-256
2. Boyle P, Langman JS. ABC of colorectal cancer: epidemiology. B.M.J. 2000;321:805-808
3. Byers T, Levin B, Rothenberger D, et al. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997; American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA. Cancer J. Clin. 1997;47:154-160
4. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N. Engl. J. Med. 1993;328:1365-1371
5. Portera CA, Berman RS, Ellis LM. Molecular determinants of colon cancer metastasis. Surg. Oncol. 1998;7:183-195
6. Wong IHN, Yeo W, Chan AT, et al. Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression. Cancer Lett. 2001;162:65-73
7. Wong IHN, Yeo W, Chan AT, et al. Quantitative correlation of cytokeratin 19 mRNA level in peripheral blood with disease stage and metastasis in breast cancer patients: potential prognostic implications. Int. J. Oncol. 2001;18:633-638
8. Shapiro B, Chakrabarty M, Cohn EM, et al. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer 1983;51:2116-2120
9. Stroun M, Anker P, Maurice P, et al. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 1989;46:318-322
10. Chen XQ, Stroun M, Magnenat JL, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med. 1996;2:1033-1035
11. Hibi K, Robinson CR, Booker S, et al. Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res. 1998; 58:1405-1407
12. Mulcahy HE, Lyautey J, Lederrey C, et al. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin. Cancer Res. 1998;4:271-275
13. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988;319:525-532
14. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767
15. Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J. Med. Genet. 1989;36:801-818
16. Perucho M. Cancer of the microsatellite mutator phenotype. Biol. Chem. 1996;377:675-684
17. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989;6.22-6.34
18. Aust DE, Terdiman JP, Willenbucher RF, et al. The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis. Cancer 2002;94:1421-1427
19. Lin SR, Tsai JH, Yang YC, et al. Mutations of K-ras oncogene in human adrenal tumours in Taiwan. Br. J. Cancer 1998;77:1060-1065
20. Wang JY, Lin SR, Hsieh JS, et al. Mutations of p53 gene in gastric carcinoma in Taiwan. Anticancer Res. 2001;21:513-520
21. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann. Surg. 1954;139:846-851
22. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987;327:293-297
23. Baker SJ, Fearon ER, Nigro JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989;244:217-221
24. Lauschke H, Caspari R, Friedl W, et al. Detection of APC and k-ras mutations in the serum of patients with colorectal cancer. Cancer Detect. Prev. 2001;25:55-61
25. Anker P, Lefort F, Vasioukhin V, et al. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 1997;112:1114-1120
26. De Kok JB, van Solinge WW, Ruers TJ, et al. Detection of tumour DNA in serum of colorectal cancer patients. Scand. J. Clin. Lab. Invest. 1997;57:601-604
27. Kopreski MS, Benko FA, Kwee C, et al. Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. Br. J. Cancer 1997;76:1293-1299
28. Gocke CD, Benko FA, Kopreski MS, et al. p53 and APC mutations are detectable in the plasma and serum of patients with colorectal cancer (CRC) or adenomas. Ann. N. Y. Acad. Sci. 2000;906:44-50
29. Soeth E, Vogel I, Roder C, et al. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res. 1997;57:3106-3110
30. Yamaguchi K, Takagi Y, Aoki S, et al. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann. Surg. 2000;232:58-65
31. Douard R, Le Maire V, Wind P, et al. Carcinoembryonic gene member 2 mRNA expression as a marker to detect circulating enterocytes in the blood of colorectal cancer patients. Surgery 2001;129:587-594
32. Vogel I, Kalthoff H. Disseminated tumour cells: their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. Virchows Arch. 2001;439:109-117